ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting) market cap is $834.46M.
What is the 52-week high for Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting) 52 week high is $18.00 as of October 10, 2025.
What is the 52-week low for Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting) 52 week low is $2.13 as of October 10, 2025.
What is Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting) stock price today?
What is the PE ratio of Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)’s P/E ratio is -8.19.
What is the Price-to-Book ratio of Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting) P/B ratio is -12.2555.
What is the 50-day moving average of Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Advanz Pharma Corp Ltd - Ordinary Shares (Limited Voting) 50-day moving average is $16.97.